Wilson's disease
Hepatolenticular degeneration · Neurology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
An autosomal recessive disorder of copper metabolism causing hepatic and neuropsychiatric disease, typically in young adults, with movement disorder, dysarthria and Kayser-Fleischer rings. Treatable and reversible if recognised early, so should be excluded in any young patient with movement disorder or unexplained liver disease.
Red flags
- Acute liver failure (coagulopathy, encephalopathy) - transplant emergency
- Neurological deterioration on starting chelation
- Haemolytic anaemia
- Severe psychiatric disturbance
- Non-adherence with therapy
Assessment
Differential diagnosis
- Other young-onset movement disorders (dystonia, parkinsonism, tremor)
- Huntington's disease
- Primary psychiatric disorder
- Autoimmune or viral hepatitis
- Drug-induced parkinsonism
- Acquired hepatocerebral degeneration
Investigations
- Serum caeruloplasmin (low) and serum copper
- 24-hour urinary copper (elevated, rises further after penicillamine challenge)
- Slit-lamp examination for Kayser-Fleischer rings
- MRI brain (basal ganglia/midbrain signal change, face of the giant panda sign)
- Liver function tests and liver synthetic function
- ATP7B genetic testing; liver biopsy copper quantification if uncertain
Management
- Suspect Wilson's in any young patient with movement disorder, unexplained liver disease or psychiatric change
- Screen with caeruloplasmin, 24-hour urinary copper and slit-lamp examination
- Confirm with genetic testing or hepatic copper quantification
- Assess hepatic and neurological severity and screen first-degree relatives
- Start copper-chelation or zinc therapy promptly
- Introduce chelators cautiously as neurological worsening can occur initially
- Advise a low-copper diet (avoid shellfish, liver, nuts, chocolate)
- Treat psychiatric and movement symptoms symptomatically
- Monitor copper indices, liver and blood counts during therapy
- Refer fulminant hepatic failure for urgent transplant assessment
Drugs & doses
Penicillamine 250 mg PO daily titrated to 1-1.5 g/day in divided doses (with pyridoxine 25 mg daily)
Trientine 300 mg PO TDS-QDS as alternative chelator (better tolerated)
Zinc acetate 50 mg PO TDS (maintenance or first-line in neurological disease)
Avoid copper-rich foods
Tetrahydromolybdate (specialist, where available) for neurological disease
Disposition
Specialist hepatology-neurology service. Lifelong treatment and monitoring. Urgent transplant referral for acute liver failure. Screen relatives.
Complications & pitfalls
- Cirrhosis and fulminant hepatic failure
- Irreversible neurological disability if untreated
- Paradoxical neurological worsening with penicillamine
- Haemolytic crises
- Treatment non-adherence relapse
Exam pearls
- Always exclude Wilson's in a young person with new movement disorder or unexplained liver disease
- Kayser-Fleischer rings are usually present when neurological features exist
- Penicillamine can transiently worsen neurology; some start zinc or trientine in neurological disease
- It is one of the few genuinely treatable neurodegenerative disorders if caught early
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.